Home LiteratureArticle Details
PMID: 17760256 Published · ppublish chi

[Clinicopathological and biological features of breast cancer in young females and their relationship with prognosis].

Zhonghua zhong liu za zhi [Chinese journal of oncology] ·Vol. 29 ·No. 4 ·2008-05-05

Meng Jie, Lang Rong-gang, Fan Yu, Fu Li

Abstract

To study the relationship between clinicopathological and biological characteristics and prognosis in young females with breast cancer.,The clinicopathological data of 99 young patients (< or =35years) with primary breast cancer were analyzed retrospectively. All the 99 patients were followed up for 5 years. The histological specimens were reviewed. The expression of ER, PR, AR, c-erbB2, ki67, p53 and BRCA1 were assessed by immunohistochemistry in 63 carcinomas.,The lymph node involvement, 5-year metastasis and 5-year survival rate were 59.6% (59/99), 28.0% (26/ 93) and 72.7% (72/99), respectively. The univariate analysis showed that the survival was related to lymphatic vessel invasion, fat involvement, node-positive status, EIC, AR and c-erbB2 expression. The COX multivariate analysis identified that only node-positive status, AR negativity and c-erbB2 overexpression were independent prognostic factors.,Our data demonstrated that the lymph node status and c-erbB2 expression are strong prognostic factors in young patients with breast cancer. AR may be an adjuvant prognostic factor. The therapeutic measurement could not benefit the outcome radically.

Article Info
Journal
Zhonghua zhong liu za zhi [Chinese journal of oncology]
Abbr.
Zhonghua Zhong Liu Za Zhi
ISSN
0253-3766
Published
2008-05-05
Indexed
2007-08-31
Updated
2015-11-19
Language
chi
Country/Region
China
NLM ID
7910681
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com